9YF0 Stock Overview
Designs, manufactures, and markets alumina-based ceramic implants in France and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
I.CERAM SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €9.64 |
52 Week High | €16.90 |
52 Week Low | €9.64 |
Beta | 1.1 |
1 Month Change | 0% |
3 Month Change | -7.31% |
1 Year Change | -3.21% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -61.75% |
Recent News & Updates
Recent updates
Shareholder Returns
9YF0 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | -2.9% | -2.6% |
1Y | -3.2% | -8.5% | 6.9% |
Return vs Industry: 9YF0 matched the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 9YF0 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
9YF0 volatility | |
---|---|
9YF0 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.3% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9YF0 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 9YF0's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 27 | André Kérisit | www.iceram.fr |
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was incorporated in 2005 and is headquartered in Limoges, France.
I.CERAM SA Fundamentals Summary
9YF0 fundamental statistics | |
---|---|
Market cap | €2.83m |
Earnings (TTM) | -€772.25k |
Revenue (TTM) | €1.56m |
1.8x
P/S Ratio-3.7x
P/E RatioIs 9YF0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9YF0 income statement (TTM) | |
---|---|
Revenue | €1.56m |
Cost of Revenue | €364.04k |
Gross Profit | €1.20m |
Other Expenses | €1.97m |
Earnings | -€772.25k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | -2.64 |
Gross Margin | 76.69% |
Net Profit Margin | -49.46% |
Debt/Equity Ratio | 123.5% |
How did 9YF0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/04/11 22:45 |
End of Day Share Price | 2023/01/12 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
I.CERAM SA is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Guillaume Cuvillier | Gilbert Dupont |
Gilbert Ferrand | TPICAP Midcap |